154 related articles for article (PubMed ID: 11774111)
1. Vitamin E-bonded hemodialyzer improves neutrophil function and oxidative stress in patients with end-stage renal failure.
Tsuruoka S; Kawaguchi A; Nishiki K; Hayasaka T; Fukushima C; Sugimoto K; Saito T; Fujimura A
Am J Kidney Dis; 2002 Jan; 39(1):127-33. PubMed ID: 11774111
[TBL] [Abstract][Full Text] [Related]
2. Effects of a vitamin E-modified dialysis membrane on neutrophil superoxide anion radical production.
Shimazu T; Ominato M; Toyama K; Yasuda T; Sato T; Maeba T; Owada S; Ishida M
Kidney Int Suppl; 2001 Feb; 78():S137-43. PubMed ID: 11168999
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
4. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters.
Satoh M; Yamasaki Y; Nagake Y; Kasahara J; Hashimoto M; Nakanishi N; Makino H
Kidney Int; 2001 May; 59(5):1943-50. PubMed ID: 11318967
[TBL] [Abstract][Full Text] [Related]
6. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.
Gritters M; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Scheffer PG; Teerlink T; Schalkwijk CG; Spreeuwenberg M; Nubé MJ
Nephrol Dial Transplant; 2006 Jan; 21(1):153-9. PubMed ID: 16144857
[TBL] [Abstract][Full Text] [Related]
7. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
8. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients.
Morimoto H; Nakao K; Fukuoka K; Sarai A; Yano A; Kihara T; Fukuda S; Wada J; Makino H
Nephrol Dial Transplant; 2005 Dec; 20(12):2775-82. PubMed ID: 16221689
[TBL] [Abstract][Full Text] [Related]
10. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease.
Nassiri AA; Hakemi MS; Soulati M; Marashian M; Rahbar K; Azizi F
Iran J Kidney Dis; 2009 Jul; 3(3):162-7. PubMed ID: 19617666
[TBL] [Abstract][Full Text] [Related]
11. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure.
Baldi S; Innocenti M; Frascerra S; Nannipieri M; Lippi A; Rindi P; Ferrannini E
J Nephrol; 2013; 26(3):549-55. PubMed ID: 22941872
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy.
Ozbasar D; Toros U; Ozkaya O; Sezik M; Uzun H; Genc H; Kaya H
J Obstet Gynaecol Res; 2010 Feb; 36(1):133-7. PubMed ID: 20178539
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin E-bonded membrane on the 8-hydroxy 2'-deoxyguanosine level in leukocyte DNA of hemodialysis patients.
Tarng DC; Huang TP; Liu TY; Chen HW; Sung YJ; Wei YH
Kidney Int; 2000 Aug; 58(2):790-9. PubMed ID: 10916104
[TBL] [Abstract][Full Text] [Related]
14. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
[TBL] [Abstract][Full Text] [Related]
15. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
Morena M; Gausson V; Mothu N; Bouchet JL; Chanas M; Grandvuillemin M; Robert A; Vela C; Canaud B; Cristol JP; Olmer M
Blood Purif; 2008; 26(3):300-10. PubMed ID: 18451643
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
[TBL] [Abstract][Full Text] [Related]
19. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
Hultqvist M; Hegbrant J; Nilsson-Thorell C; Lindholm T; Nilsson P; Lindén T; Hultqvist-Bengtsson U
Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]